{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:22:06Z","timestamp":1791588126994,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejso.2025.110413","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T15:55:59Z","timestamp":1756137359000},"page":"110413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prostate cancer in Nigeria: a scoping review and meta-analysis of current evidence on process indicators and interventions"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4296-9744","authenticated-orcid":false,"given":"Musliu Adetola","family":"Tolani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathishrajaa","family":"Palaniraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaharaddeen Shuaibu","family":"Babandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dutse Musa","family":"Gimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2025.110413_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2025.110413_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.urolonc.2024.07.014","article-title":"Barriers and facilitators of the application of precision medicine to the genitourinary cancer care pathway: perspective from a low- and middle- income country in Sub-Saharan Africa","volume":"42","author":"Tolani","year":"2024","journal-title":"Urol Oncol: Seminars and Original Investigations"},{"key":"10.1016\/j.ejso.2025.110413_bib3","series-title":"Global cancer observatory: cancer today (version 1.1)","author":"Ferlay","year":"2024"},{"key":"10.1016\/j.ejso.2025.110413_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/2250-9658.197437","article-title":"Incidence of hospital-based screen-detected prostate cancer in Abuja, Nigeria","volume":"5","author":"Aisuodionoe-Shadrach","year":"2016","journal-title":"New Niger J Clin Res"},{"key":"10.1016\/j.ejso.2025.110413_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/jammr\/2019\/v31i530297","article-title":"Presentation, characteristics, and co-morbidities of men with prostate cancer in Nigeria","volume":"31","author":"Ofoha","year":"2019","journal-title":"J Adv Med Med Res"},{"key":"10.1016\/j.ejso.2025.110413_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm14010084","article-title":"Health policy for prostate cancer early detection in the european union and the impact of opportunistic screening: PRAISE-U consortium","volume":"14","author":"Beyer","year":"2024","journal-title":"J Personalized Med"},{"key":"10.1016\/j.ejso.2025.110413_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.canlet.2021.11.033","article-title":"The prostate cancer landscape in Europe: current challenges, future opportunities","volume":"526","author":"Marhold","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejso.2025.110413_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eclinm.2024.103022","article-title":"Monitoring of prostate cancer screening in the european union: development of key performance indicators through the PRAISE-U project","volume":"80","author":"Singh","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ejso.2025.110413_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol Theory Pract"},{"key":"10.1016\/j.ejso.2025.110413_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejso.2025.110413_bib11","series-title":"JBI manual for evidence synthesis","year":"2024"},{"key":"10.1016\/j.ejso.2025.110413_bib12","first-page":"1","article-title":"Metaprop: a stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Heal"},{"key":"10.1016\/j.ejso.2025.110413_bib13","author":"Wells"},{"key":"10.1016\/j.ejso.2025.110413_bib14","first-page":"72","article-title":"Chapter 3: systematic reviews of effectiveness","volume":"vol. 3","author":"Tufanaru","year":"2020"},{"key":"10.1016\/j.ejso.2025.110413_bib15","first-page":"1","article-title":"Quality assessment with diverse studies (QuADS): an appraisal tool for methodological and reporting quality in systematic reviews of mixed- or multimethod studies","volume":"21","author":"Harrison","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ejso.2025.110413_bib16","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S1470-2045(19)30625-4","article-title":"Navigating prostate cancer control in Nigeria","volume":"20","author":"Chidebe","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.110413_bib17","series-title":"Prostate cancer screening and awareness program","year":"2022"},{"key":"10.1016\/j.ejso.2025.110413_bib18","series-title":"EAU - EAeanm ESTRO - ESUR - ISUP - SIOG guidelines on prostate cancer","author":"Cornford","year":"2025"},{"key":"10.1016\/j.ejso.2025.110413_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.14740\/wjon1221","article-title":"A review of localized prostate cancer: an African perspective","volume":"10","author":"Cassell","year":"2019","journal-title":"World J Oncol"},{"key":"10.1016\/j.ejso.2025.110413_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/1785428","article-title":"Management of advanced and metastatic prostate cancer: a need for a sub-saharan guideline","author":"Cassell","year":"2019","journal-title":"J Oncol"},{"key":"10.1016\/j.ejso.2025.110413_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3332\/ecancer.2025.1862","article-title":"Understanding the needs of African researchers involved in implementation and dissemination science","volume":"19","author":"Lasebikan","year":"2025","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.ejso.2025.110413_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0223537","article-title":"Patient navigation services for cancer care in low-and middle-income countries: a scoping review","volume":"14","author":"Dalton","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2025.110413_bib23","first-page":"1","article-title":"Comparison of health access, lifestyle, prostate cancer knowledge and screening among black men residing in West Africa and the USA","volume":"15","author":"Col\u00f3n","year":"2021","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.ejso.2025.110413_bib24","first-page":"231","article-title":"Risk perception and uptake of prostate cancer screening among a population of civil servants in Ibadan, Nigeria","volume":"24","author":"Ndikom","year":"2021","journal-title":"Afr J Biomed Res"},{"key":"10.1016\/j.ejso.2025.110413_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/aam.aam_101_20","article-title":"Prostate cancer characteristics: a descriptive analysis of clinical features at presentation in the last decade in a black African community","volume":"21","author":"Ugwumba","year":"2022","journal-title":"Ann Afr Med"},{"key":"10.1016\/j.ejso.2025.110413_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/npmj.npmj_70_22","article-title":"Prevalence of skeletal-related events in hormone-na\u00efve prostate cancer in a low resource setting","volume":"29","author":"Ugwumba","year":"2022","journal-title":"Niger Postgrad Med J"},{"key":"10.1016\/j.ejso.2025.110413_bib27","first-page":"1","article-title":"Distribution of cancer and cancer screening and treatment services in Lagos: a 10-year review of hospital records","volume":"8","author":"Omosun","year":"2022","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.ejso.2025.110413_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12301-022-00273-y","article-title":"A comparison of clinicopathologic features of prostate cancer between Nigerian and South African black men","volume":"28","author":"Ahmed","year":"2022","journal-title":"Afr J Urol"},{"key":"10.1016\/j.ejso.2025.110413_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/njbcs.njbcs_44_22","article-title":"Histopathological correlations of serum prostate specific antigen (PSA) and tumor grade among prostate cancer patients in Kano, Nigeria","volume":"20","author":"Abdullahi","year":"2023","journal-title":"Niger J Basic Clin Sci"},{"key":"10.1016\/j.ejso.2025.110413_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/jphia.2023.2134","article-title":"Awareness, knowledge, and factors that influenced the uptake of screening tests for prostate cancer among men aged 40 and older in Ido-Ekiti, Ekiti state, Nigeria","volume":"14","author":"Adewoye","year":"2023","journal-title":"J Publ Health Afr"},{"key":"10.1016\/j.ejso.2025.110413_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/15579883241264949","article-title":"Pattern, clinical characteristics, and impact of family history on prostate-specific antigen in prostate cancer: a multicenter study","volume":"18","author":"Iheanacho","year":"2024","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.ejso.2025.110413_bib32","first-page":"265","article-title":"Rural population and prostate cancer screening exercise in southeast Nigeria: implication to public health policy and sustainable development","volume":"39","author":"Izueke","year":"2024","journal-title":"Turk Onkol Derg"},{"key":"10.1016\/j.ejso.2025.110413_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3332\/ecancer.2024.1740","article-title":"Sociodemographic and clinicopathologic characteristics of patients treated with high dose rate prostate brachytherapy in Nigeria","volume":"18","author":"Abdus-Salam","year":"2024","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.ejso.2025.110413_bib34","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4103\/njcp.njcp_219_19","article-title":"Apical peri-prostatic nerve block versus intra-rectal xylocaine gel for trans- rectal ultrasound guided prostate biopsy among Nigerian patients: a prospective randomized study","volume":"23","author":"Ezenwa","year":"2020","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.ejso.2025.110413_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4103\/npmj.npmj_297_20","article-title":"Survey of prostate biopsy practices among urologists in Nigeria","volume":"27","author":"Jeje","year":"2020","journal-title":"Niger Postgrad Med J"},{"key":"10.1016\/j.ejso.2025.110413_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12301-021-00258-3","article-title":"Prophylactic role of ciprofloxacin and ceftriaxone in prostate biopsy-related infection: randomized comparative study of bacterial spectrum and antibiotic sensitivities","volume":"27","author":"Odo","year":"2021","journal-title":"Afr J Urol"},{"key":"10.1016\/j.ejso.2025.110413_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/UA.UA_136_20","article-title":"Detection rate of prostate cancer following 12-core extended biopsy in a semi-urban Nigerian tertiary hospital","volume":"13","author":"Ogbetere","year":"2021","journal-title":"Urol Ann"},{"key":"10.1016\/j.ejso.2025.110413_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s13139-021-00735-1","article-title":"A bone scan is valuable for primary staging of newly diagnosed prostate cancer in a low-resource setting (Nigeria)","volume":"56","author":"Orunmuyi","year":"2022","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2025.110413_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12301-020-00036-7","article-title":"Bone mineral density in Nigerian men on androgen deprivation therapy for advanced prostate cancer","volume":"26","author":"Ojewuyi","year":"2020","journal-title":"Afr J Urol"},{"key":"10.1016\/j.ejso.2025.110413_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/npmj.npmj_146_19","article-title":"Lower urinary tract symptoms in patients with advanced prostate cancer: what are the outcomes of androgen deprivation therapy?","volume":"27","author":"Akpayak","year":"2020","journal-title":"Niger Postgrad Med J"},{"key":"10.1016\/j.ejso.2025.110413_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.573036","article-title":"10-year mortality pattern among cancer patients in Lagos state university teaching hospital, Ikeja, Lagos","volume":"10","author":"Fatiregun","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2025.110413_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/ijmbs.ijmbs_30_21","article-title":"Cancer mortality pattern in a resource-poor country: a case study of a teaching hospital in the southeast region of Nigeria","volume":"13","author":"Ndukwe","year":"2021","journal-title":"Ibnosina J Med Biomed Sci"},{"key":"10.1016\/j.ejso.2025.110413_bib43","first-page":"104","article-title":"Dosimetric evaluation of intensity modulated radiotherapy and three-dimensional conformal radiotherapy treatment plans for prostate cancer","volume":"36","author":"Adeneye","year":"2021","journal-title":"Turk Onkol Derg"},{"key":"10.1016\/j.ejso.2025.110413_bib44","first-page":"219","article-title":"Simultaneous integrated boost plan: comparison between volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) for prostate, seminal vesicle and lymph node irradiation","volume":"6","author":"Adeneye","year":"2022","journal-title":"Eurasian J Med Oncol"},{"key":"10.1016\/j.ejso.2025.110413_bib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4314\/ahs.v23i1.50","article-title":"Surgical androgen deprivation therapy in advanced prostate cancer in patients of African descent: comparison of biochemical efficacy of bilateral total and subcapsular orchidectomy","volume":"23","author":"Arogundade","year":"2023","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.ejso.2025.110413_bib46","first-page":"116","article-title":"Lived experiences of prostate cancer patients in an urban metropolis in North central Nigeria","volume":"27","author":"Kolapo","year":"2023","journal-title":"Afr J Reprod Health"},{"key":"10.1016\/j.ejso.2025.110413_bib47","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4103\/njcp.njcp_453_23","article-title":"Surgical outcome of open radical prostatectomy in Nigeria: a five-years single-surgeon experience","volume":"27","author":"Osaghae","year":"2024","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.ejso.2025.110413_bib48","first-page":"1","article-title":"Radiotherapy waiting time in northern Nigeria: experience from a resource-limited setting","volume":"14","author":"Tumba","year":"2021","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.ejso.2025.110413_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12301-021-00173-7","article-title":"Examining the influence of illness perception and financial toxicity on the quality of life of prostate cancer patients","volume":"27","author":"Akin-Odanye","year":"2021","journal-title":"Afr J Urol"},{"key":"10.1016\/j.ejso.2025.110413_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.618641","article-title":"Hypofractionated radiotherapy in African cancer centers","volume":"10","author":"Swanson","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2025.110413_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5534683","article-title":"Waiting times for prostate cancer diagnosis in a Nigerian population","volume":"2021","author":"Omisanjo","year":"2021","journal-title":"J Cancer Epidemiol"},{"key":"10.1016\/j.ejso.2025.110413_bib52","first-page":"46","article-title":"Willingness-to-pay for a population-based-prostate-specific antigen screening for prostate cancer in Anambra state, Southeast, Nigeria: a contingent valuation study","volume":"22","author":"Umeh","year":"2022","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.ejso.2025.110413_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2023.1136357","article-title":"Expanding radiotherapy access in Sub-Saharan Africa: an analysis of travel burdens and patient-related benefits of hypofractionation","volume":"13","author":"Patel","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2025.110413_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-024-11340-1","article-title":"Detection and management of localized prostate cancer in Nigeria: barriers and facilitators according to patients, caregivers and healthcare providers","volume":"24","author":"Tolani","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ejso.2025.110413_bib55","first-page":"317","article-title":"Waiting times in prostate cancer diagnosis and treatment: a ten-year experience in a Nigerian teaching hospital","volume":"41","author":"Okeke","year":"2024","journal-title":"W Afr J Med"},{"key":"10.1016\/j.ejso.2025.110413_bib56","doi-asserted-by":"crossref","first-page":"e751","DOI":"10.1093\/ajhp\/zxae193","article-title":"Impact of a pharmacist-led intervention on prostate cancer illness perception","volume":"81","author":"Iheanacho","year":"2024","journal-title":"Am J Heal Pharm"},{"key":"10.1016\/j.ejso.2025.110413_bib57","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1200\/GO.20.00290","article-title":"Impact of androgen deprivation on oxidative stress and antioxidant status in Nigerian patients with prostate cancer undergoing androgen deprivation therapy","volume":"6","author":"Bassey","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.ejso.2025.110413_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12301-019-0013-2","article-title":"Assessment of the value of the different variants of abnormal digital rectal examination finding in predicting carcinoma of the prostate: a preliminary report of a two-center study","volume":"26","author":"Irekpita","year":"2020","journal-title":"Afr J Urol"},{"key":"10.1016\/j.ejso.2025.110413_bib59","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1158\/0008-5472.CAN-19-2165","article-title":"A custom genotyping array reveals population-level heterogeneity for the genetic risks of prostate cancer and other cancers in Africa","volume":"80","author":"Harlemon","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2025.110413_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11604\/pamj.2020.36.251.21419","article-title":"Treatment of localized prostate cancer and use of nomograms among urologists in the West Africa sub-region","volume":"36","author":"Kyei","year":"2020","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.ejso.2025.110413_bib61","first-page":"159","article-title":"Update of guidelines for management of prostate cancer in west Africa 2019: consensus working document","volume":"37","author":"Osaghae","year":"2020","journal-title":"W Afr J Med"},{"key":"10.1016\/j.ejso.2025.110413_bib62","first-page":"285","article-title":"Assessment of essential and non-essential elements as risk evaluation indices in men with prostate cancer in Calabar, South-South Nigeria","volume":"13","author":"Nsonwu-Anyanwu","year":"2022","journal-title":"Middle East J Cancer"},{"key":"10.1016\/j.ejso.2025.110413_bib63","first-page":"1205","article-title":"Quest to improve management of prostate cancer in West Africa: development of a clinical audit tool","volume":"39","author":"Osaghae","year":"2022","journal-title":"W Afr J Med"},{"key":"10.1016\/j.ejso.2025.110413_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10732748221081366","article-title":"Determination of serum prostate specific antigen levels amongst apparently healthy Nigerian males in a university and university hospital community in the federal capital territory","volume":"29","author":"Aisuodionoe-Shadrach","year":"2022","journal-title":"Cancer Control"},{"key":"10.1016\/j.ejso.2025.110413_bib65","first-page":"1","article-title":"Diagnostic potential value of circulating PCA3 mRNA in plasma and urine of prostate cancer patients","volume":"17","author":"Akinloye","year":"2022","journal-title":"Sci Afr"},{"key":"10.1016\/j.ejso.2025.110413_bib66","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2021.12.023","article-title":"A rare germline HOXB13 variant contributes to risk of prostate cancer in men of African ancestry","volume":"81","author":"Darst","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2025.110413_bib67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/aihb.aihb_139_22","article-title":"Audit of prostate cancer diagnosis using P63 and prostate-specific antigen immunostains at a tertiary care hospital in south-east Nigeria","volume":"13","author":"Amadi","year":"2023","journal-title":"Adv Hum Biol"},{"key":"10.1016\/j.ejso.2025.110413_bib68","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4103\/njcp.njcp_1643_21","article-title":"Need for age-specific prostate-specific antigen reference intervals in a Nigerian population","volume":"26","author":"Okafor","year":"2023","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.ejso.2025.110413_bib69","first-page":"1","article-title":"Assessment of quality of life of prostate cancer patients receiving care in university of Nigeria teaching hospital, Ituku-Ozalla, Enugu state","volume":"21","author":"Dim","year":"2024","journal-title":"Discov Public Heal"},{"key":"10.1016\/j.ejso.2025.110413_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-024-02318-y","article-title":"Defining the relationship between clinician-preferred ECOG performance status and patient-reported health-related quality of life scores in men with metastatic hormone-na\u00efve prostate cancer","volume":"22","author":"Nnabugwu","year":"2024","journal-title":"Health Qual Life Outcome"},{"key":"10.1016\/j.ejso.2025.110413_bib71","first-page":"1","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325008418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325008418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:23:08Z","timestamp":1761963788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325008418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":71,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0748798325008418"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110413","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer in Nigeria: a scoping review and meta-analysis of current evidence on process indicators and interventions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110413"}}